Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 6/20 | 0.68 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21821935 | 1.00 | MAP1LC3B (0.68) | MAP1LC3BCHRNB2CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL1781754 | 0.81 | MAP1LC3B (1.00) | MAP1LC3BMEN1KMT2A | |
| SCHEMBL22111698 | 0.81 | MAP1LC3B (0.44) | MAP1LC3BCHRNB2CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL1779869 | 0.76 | MAP1LC3B (1.00) | MAP1LC3BMEN1KMT2ATSHR | |
| SCHEMBL21822056 | 0.76 | MAP1LC3B (0.68) | MAP1LC3BCHRNB2CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL21821964 | 0.75 | MAP1LC3B (0.71) | MAP1LC3BMEN1KMT2A | |
| SCHEMBL1780581 | 0.75 | MAP1LC3B (1.00) | MAP1LC3BMEN1KMT2A | |
| SCHEMBL21821985 | 0.75 | MAP1LC3B (0.74) | MAP1LC3BMEN1KMT2AGAA | |
| SCHEMBL1780317 | 0.74 | MAP1LC3B (1.00) | MAP1LC3BMEN1KMT2AGAA | |
| SCHEMBL21774003 | 0.72 | MAP1LC3B (0.70) | MAP1LC3BMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | ATG7, SQSTM1, BECN1 | MAP1LC3B 15/4885CHRNB2 4711/4885CHRNA3 4787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.